RU
Pulmonology
Ipratropium Air
Registration certificate:
LP-007385
INN:
Ipratropium Bromide
Release form:
Metered Dose Inhaler (MDI)
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
M-holinoblocker
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • Pulmonary Emphysema
  • Bronchial Asthma (especially with concomitant cardiovascular conditions)

Included in the Essential Medicines List

Using Ipratropium Air
 
Quality control
at all stages of production